Crispr/cas-related methods and compositions for knocking out c5
US-2024415980-A1 · Dec 19, 2024 · US
US9085609B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9085609-B2 |
| Application number | US-48448506-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 11, 2006 |
| Priority date | Sep 4, 1998 |
| Publication date | Jul 21, 2015 |
| Grant date | Jul 21, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method is provided for producing motif-specific, context-independent antibodies that recognize a plurality of peptides or proteins within a genome that contain the same post-translationally modified motif. The method includes the step of immunizing a host with a degenerate peptide library antigen featuring (i) a fixed target motif containing one or more invariant amino acids including at least one modified amino acid, and (ii) a plurality of degenerate amino acids flanking the motif. Motif-specific, context-independent antibodies produced by the disclosed method are also provided. The method encompasses motifs consisting of a single modified amino acid, as well as short motifs comprising multiple invariant amino acids including one or more modified amino acids, such as all or part of kinase consensus substrate motifs, protein-protein binding motifs, or other cell signaling motifs. Methods of using the antibodies, e.g. for genome-wide profiling, are also provided.
Opening claim text (preview).
What is claimed is: 1. A purified motif-specific, context-independent antibody that specifically binds a motif consisting of (i) two to six invariant amino acids including at least one methylated amino acid, and, optionally, (ii) one or more degenerate amino acid position(s), wherein said motif is selected from the group consisting of monomethylarginine-G-G, monomethylarginine-G-G-monomethylarginine-G-G (SEQ ID NO: 311), monomethylarginine-X-monomethylarginine, monomethylarginine-G, and G-monomethylarginine-G and wherein said antibody specifically binds said motif in a plurality of non-homologous peptides or proteins within an organism. 2. A purified motif-specific, context-independent antibody that specifically binds a motif consisting of (i) two to six invariant amino acids including at least one acetylated amino acid, and, optionally, (ii) one or more degenerate amino acid position(s), wherein said motif is selected from the group consisting of XXkXXXK, XXGkXX, XXkXE, XXKkXX, XXEkXX, XXkLXX, and XXkXEXKXX, wherein k=acetyl-lysine, and wherein said antibody specifically binds said motif in a plurality of non-homologous peptides or proteins within an organism. 3. A purified motif-specific, context-independent antibody that specifically binds a motif consisting of (i) two to six invariant amino acids including at least one phosphorylated amino acid, and, optionally, (ii) one or more degenerate amino acid position(s), wherein said motif is selected from the group consisting of phosphothreonine-X-phosphotyrosine, phosphothreonine-Glu-phosphotyrosine, and Pro-X-Ile-X-Ile-phosphothreonine (SEQ ID NO: 277), and wherein said antibody specifically binds said motif in a plurality of non-homologous peptides or proteins within an organism. 4. A purified motif-specific, context-independent antibody that specifically binds a motif consisting of (i) two to six invariant amino acids including at least one methylated amino acid, and, optionally, (ii) one or more degenerate amino acid position(s), wherein said motif is selected from the group consisting of (symmetric dimethylarginine)-G-G, (symmetric dimethylarginine)-G-G-(symmetric dimethylarginine)-G-G (SEQ ID NO: 311), (symmetric dimethylarginine)-X-(symmetric dimethylarginine), and (symmetric dimethylarginine)-G and wherein said antibody specifically binds said motif in a plurality of non-homologous peptides or proteins within an organism. 5. A purified motif-specific, context-independent antibody that specifically binds a motif consisting of (i) two to six invariant amino acids including at least one methylated amino acid, and, optionally, (ii) one or more degenerate amino acid position(s), wherein said motif is selected from the group consisting of (asymmetric dimethylarginine)-G-G, (asymmetric dimethylarginine)-G-G-(asymmetric dimethylarginine)-G-G (SEQ ID NO: 311), (asymmetric dimethylarginine)-X-(asymmetric dimethylarginine), (asymmetric dimethylarginine)-G, and G-(asymmetric dimethylarginine)-G and wherein said antibody specifically binds said motif in a plurality of non-homologous peptides or proteins within an organism. 6. The purified motif-specific, context-independent antibody of claim 1 , wherein said motif is monomethylarginine-G-G. 7. The purified motif-specific, context-independent antibody of claim 4 , wherein said motif is (symmetric dimethylarginine)-G. 8. The purified motif-specific, context-independent antibody of claim 1 , wherein the antibody is a monoclonal antibody. 9. The purified motif-specific, context-independent antibody of claim 2 , wherein the antibody is a monoclonal antibody. 10. The purified motif-specific, context-independent antibody of claim 3 , wherein the antibody is a monoclonal antibody. 11. The purified motif-specific, context-independent antibody of claim 4 , wherein the antibody is a monoclonal antibody. 12. The purified motif-specific, context-independent antibody of claim 5 , wherein the antibody is a monoclonal antibody. 13. The purified motif-specific, context-independent antibody of claim 6 , wherein the antibody is a monoclonal antibody. 14. The purified motif-specific, context-independent antibody of claim 7 , wherein the antibody is a monoclonal antibody.
against material from animals or humans · CPC title
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title
against material not provided for elsewhere {, e.g. haptens, metals, DNA, RNA, amino acids} · CPC title
characterized by taxonomic origin · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.